Molecularmd
Get Full AccessDescription
- MolecularMD Corporation develops and commercializes specialty molecular diagnostics for oncology applications. Its tests are designed to allow appropriate selection, monitoring and management of patients treated with molecularly targeted cancer therapies. MolecularMDs assays incorporate both gold-standard and innovative technologies to provide highly sensitive, standardized, reliable results that support clinical development, regulatory approval, and commercialization of novel anticancer agents. A private company based in Portland, Oregon, MolecularMD was founded by Brian Druker, director of the Knight Cancer Center at Oregon Health & Science University and lead clinical investigator for Gleevec, and Sheridan G. Snyder, entrepreneur and founder of Genzyme Corporation and Upstate Biotechnology.
-
Headquarters:1341 Southwest Custer Drive , Portland, Oregon, United States
More -
Phone Number: +1 503-459-4974
-
Website: https://www.molecularmd.com
-
Employees:66
-
Revenue:$50 - 100M
-
Legal Name:Molecularmd
-
Molecularmd's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Molecularmd
-
Where are Molecularmd's Headquarters?
Molecularmd's Headquarters are in 1341 Southwest Custer Drive ,Portland,Oregon,United States
-
What is Molecularmd's phone number?
Molecularmd's phone number is +1 503-459-4974
-
What is Molecularmd's official website?
Molecularmd's official website is https://www.molecularmd.com
-
What is Molecularmd's Revenue?
Molecularmd's revenue is $50 - 100M
-
What is Molecularmd's NAICS code?
Molecularmd's NAICS code is 541713
-
How many employees are working in Molecularmd
Molecularmd has 66 employees
-
What is Molecularmd's Industry?
Molecularmd is in the industry of Biotechnology
-
Who is Molecularmd's Chief Strategy Officer?
Molecularmd's Chief Strategy Officer is Stephane Wong

